T1	Participants 180 188	patients
T2	Participants 365 386	hypertensive patients
T3	Participants 388 396	Patients
T4	Participants 567 580	nonresponders
T5	Participants 770 789	ll treatment groups
T6	Participants 837 845	patients
T7	Participants 1259 1282	hypertensive patients a
